Quantitation of tadalafil in human plasma by liquid chromatography-tandem mass spectrometry with electrospray ionization

被引:53
作者
Ramakrishna, NVS [1 ]
Vishwottam, KN [1 ]
Puran, S [1 ]
Koteshwara, M [1 ]
Manoj, S [1 ]
Santosh, M [1 ]
Chidambara, J [1 ]
Wishu, S [1 ]
Sumatha, B [1 ]
机构
[1] Suven Life Sci Ltd, Biopharmaceut Res, Hyderabad 500034, Andhra Pradesh, India
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2004年 / 809卷 / 02期
关键词
tadalafil;
D O I
10.1016/j.jchromb.2004.06.026
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A simple, rapid, sensitive and specific liquid chromatography-tandem mass spectrometry method was developed and validated for quantitation of tadalafil (I) in human plasma, a new selective, reversible phosphodiesterase 5 inhibitor. The analyte and internal standard (sildenatil, II) were extracted by liquid-liquid extraction with diethyl ether/dichloromethane (70/30, v/v) using a Glas-Col Multi-Pulse Vortexer. The chromatographic separation was performed on reverse phase Xterra MS C18 column with a mobile phase of 10 mM ammonium formate/acetonitrile (10/90, v/v, pH adjusted to 3.0 with formic acid). The protonate of analyte was quantitated in positive ionization by multiple reaction monitoring with a mass spectrometer. The mass transitions m/z 390.4 --> 268.0 and m/z 475.5 --> 58.3 were used to measure I and II, respectively. The assay exhibited a linear dynamic range of 10-1000 ng/mL for tadalafil in human plasma. The lower limit of quantitation was 10 ng/mL with a relative standard deviation of less than 15%. Acceptable precision and accuracy were obtained for concentrations over the standard curve ranges. Run time of 1.2 min for each sample made it possible to analyze a throughput of more than 400 human plasma samples per day. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic, bioavailability or bioequivalence studies. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:243 / 249
页数:7
相关论文
共 14 条
[1]  
[Anonymous], GUID IND BIOAN METH
[2]   Oral agents: First-line therapy for erectile dysfunction [J].
Brock, G .
EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (08) :12-18
[3]   Tadalafil [J].
Curran, MP ;
Keating, GM .
DRUGS, 2003, 63 (20) :2203-2212
[4]  
Gaines Kaye K, 2004, Urol Nurs, V24, P46
[5]  
Gresser U, 2002, EUR J MED RES, V7, P435
[6]  
Jemal M, 2000, BIOMED CHROMATOGR, V14, P422, DOI 10.1002/1099-0801(200010)14:6<422::AID-BMC25>3.0.CO
[7]  
2-I
[8]  
Lee MS, 1999, MASS SPECTROM REV, V18, P187, DOI 10.1002/(SICI)1098-2787(1999)18:3/4<187::AID-MAS2>3.0.CO
[9]  
2-K
[10]  
PATTERSON B, 2001, INT J IMPOT RES S4, V13, P43